An ITPA Enzyme with Improved Substrate Selectivity

Overview

Journal Protein J

Publisher Springer

Specialty Biochemistry

Date 2023 Dec 8

PMID 38066288

Authors

Nicholas E Burgis

Kandise VanWormer

Devin Robbins

Jonathan Smith

Affiliations

Soon will be listed here.

Abstract

Recent clinical data have identified infant patients with lethal ITPA deficiencies. ITPA is known to modulate ITP concentrations in cells and has a critical function in neural development which is not understood. Polymorphism of the ITPA gene affects outcomes for both ribavirin and thiopurine based therapies and nearly one third of the human population is thought to harbor ITPA polymorphism. In a previous site-directed mutagenesis alanine screen of the ITPA substrate selectivity pocket, we identified the ITPA mutant, E22A, as a gain-of function mutant with enhanced ITP hydrolysis activity. Here we report a rational enzyme engineering experiment to investigate the biochemical properties of position 22 ITPA mutants and find that the E22D ITPA has two- and four-fold improved substrate selectivity for ITP over the canonical purine triphosphates ATP and GTP, respectively, while maintaining biological activity. The novel E22D ITPA should be considered as a platform for further development of ITPA therapies.

References

Jimmerson L, Bushman L, Ray M, Anderson P, Kiser J . A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells. Pharm Res. 2016; 34(1):73-83. PMC: 5177511. DOI: 10.1007/s11095-016-2040-z. View

Handley M, Reddy K, Wills J, Rosser E, Kamath A, Halachev M . ITPase deficiency causes a Martsolf-like syndrome with a lethal infantile dilated cardiomyopathy. PLoS Genet. 2019; 15(3):e1007605. PMC: 6428344. DOI: 10.1371/journal.pgen.1007605. View

Burgess R, Wang S, McTague A, Boysen K, Yang X, Zeng Q . The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures. Ann Neurol. 2019; 86(6):821-831. PMC: 7423163. DOI: 10.1002/ana.25619. View

Birerdinc A, Estep M, Afendy A, Stepanova M, Younossi I, Baranova A . Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C). J Viral Hepat. 2012; 19(6):414-22. DOI: 10.1111/j.1365-2893.2011.01564.x. View

Rahban M, Zolghadri S, Salehi N, Ahmad F, Haertle T, Rezaei-Ghaleh N . Thermal stability enhancement: Fundamental concepts of protein engineering strategies to manipulate the flexible structure. Int J Biol Macromol. 2022; 214:642-654. DOI: 10.1016/j.ijbiomac.2022.06.154. View

Rembeck K, Waldenstrom J, Hellstrand K, Nilsson S, Nystrom K, Martner A . Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. Hepatology. 2014; 59(6):2131-9. DOI: 10.1002/hep.27009. View

Segel G, Cokelet G, Lichtman M . The measurement of lymphocyte volume: importance of reference particle deformability and counting solution tonicity. Blood. 1981; 57(5):894-9. View

Raguram A, Banskota S, Liu D . Therapeutic in vivo delivery of gene editing agents. Cell. 2022; 185(15):2806-2827. PMC: 9454337. DOI: 10.1016/j.cell.2022.03.045. View

Yoneshima Y, Abolhassani N, Iyama T, Sakumi K, Shiomi N, Mori M . Deoxyinosine triphosphate induces MLH1/PMS2- and p53-dependent cell growth arrest and DNA instability in mammalian cells. Sci Rep. 2016; 6:32849. PMC: 5020429. DOI: 10.1038/srep32849. View

10.

Jimmerson L, Urban T, Truesdale A, Baouchi-Mokrane F, Kottilil S, Meissner E . Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels. J Clin Pharmacol. 2016; 57(1):118-124. PMC: 10725569. DOI: 10.1002/jcph.783. View

11.

Kouwenberg T, van den Bosch B, Bierau J, Te Loo D, Coenen M, Hagleitner M . Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment. J Pediatr Hematol Oncol. 2020; 42(2):e94-e97. DOI: 10.1097/MPH.0000000000001707. View

12.

Alcon-Grases M, Ferrer-Aliaga N, Salinas-Salvador B, Perez-Delgado R, Castejon-Ponce E, Garcia-Jimenez M . [Early infantile epileptic encephalopathy due to ITPA mutation]. Rev Neurol. 2020; 71(5):197-198. DOI: 10.33588/rn.7105.2020239. View

13.

Burgis N, Cunningham R . Substrate specificity of RdgB protein, a deoxyribonucleoside triphosphate pyrophosphohydrolase. J Biol Chem. 2006; 282(6):3531-8. DOI: 10.1074/jbc.M608708200. View

14.

Nakauchi A, Hao Wong J, Mahasirimongkol S, Yanai H, Yuliwulandari R, Mabuchi A . Identification of ITPA on chromosome 20 as a susceptibility gene for young-onset tuberculosis. Hum Genome Var. 2016; 3:15067. PMC: 4760120. DOI: 10.1038/hgv.2015.67. View

15.

Schroader J, Handley M, Reddy K . Inosine triphosphate pyrophosphatase: A guardian of the cellular nucleotide pool and potential mediator of RNA function. Wiley Interdiscip Rev RNA. 2023; 14(5):e1790. DOI: 10.1002/wrna.1790. View

16.

Scala M, Wortmann S, Kaya N, Stellingwerff M, Pistorio A, Glamuzina E . Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022; 43(3):403-419. PMC: 9152572. DOI: 10.1002/humu.24326. View

17.

Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N . Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet. 2011; 20(17):3507-16. DOI: 10.1093/hmg/ddr249. View

18.

Garg M, Goraya J, Kochar G, Jain V . ITPA-associated developmental and epileptic encephalopathy: characteristic neuroradiological features with novel clinical and biochemical findings. Epileptic Disord. 2022; 24(3):583-588. DOI: 10.1684/epd.2022.1424. View

19.

Fellay J, Thompson A, Ge D, Gumbs C, Urban T, Shianna K . ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature. 2010; 464(7287):405-8. DOI: 10.1038/nature08825. View

20.

Sumi S, Marinaki A, Arenas M, Fairbanks L, Rees D, Thein S . Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet. 2002; 111(4-5):360-7. DOI: 10.1007/s00439-002-0798-z. View